Doctor Steven Deitelzweig
Ochsner Medical Center, New Orleans (United States of America)
Incidence and delays of a new clinical atrial fibrillation diagnosis following an atrial fibrillation detection signal on a personal electrocardiogram device available to consumers
Event: ESC Congress 2023
Topic: Atrial Stressors
Session: Atrial fibrillation: beyond stroke prevention and rhythm control
Clinical impact of switching or continuation of apixaban or rivaroxaban among patients with non-valvular atrial fibrillation
Event: ESC Congress 2023
Topic: Anticoagulants
Session: Oral anticoagulation in patients with atrial fibrillation
Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.
Event: ESC Congress 2022
Topic: Atrial Fibrillation (AF)
Session: Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice
Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.
Event: ESC Congress 2022
Topic: Atrial Fibrillation (AF)
Session: Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice
Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.
Event: ESC Congress 2022
Topic: Atrial Fibrillation (AF)
Session: Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice
Real-world evidence complements randomised controlled trial data to inform daily clinical practice.
Event: ESC Congress 2022
Topic: Atrial Fibrillation (AF)
Session: Real-world evidence in practice: stroke prevention with non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation
Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.
Event: ESC Congress 2021 - The Digital Experience
Topic: Atrial Fibrillation (AF)
Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials
Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.
Event: ESC Congress 2021 - The Digital Experience
Topic: Atrial Fibrillation (AF)
Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials
Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.
Event: ESC Congress 2021 - The Digital Experience
Topic: Atrial Fibrillation (AF)
Session: Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials
Comparison of stroke and major bleeding risk of treatment with apixaban vs. rivaroxaban and dabigatran among elderly nonvalvular atrial fibrillation patients in the United States
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Anticoagulation in atrial fibrillation
ESC 365 is supported by
